Entera Bio (ENTX) Return on Invested Capital (2021 - 2024)

Entera Bio has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.01% for Q4 2024.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.01% (changed 0.0% YoY) and the FY2024 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital eased to 0.01% in Q4 2024, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q4 2021 and troughed at 0.01% in Q3 2023.
• A 4-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2022 — Return on Invested Capital slipped 1 bps — and 2023, when it changed 0 bps.
• Tracing ENTX's Return on Invested Capital over 4 years: stood at 0.0% in 2021, then slumped by 103 bps to 0.01% in 2022, then dropped by 6 bps to 0.01% in 2023, then retreated by 24 bps to 0.01% in 2024.
• Business Quant data shows ENTX's Return on Invested Capital at 0.01% in Q4 2024, 0.01% in Q3 2024, and 0.01% in Q4 2023.